+39 06 99775399 info@reithera.com

Italiano
English

ReiThera collaborates with the MAGIC consortium to support the development of gene therapies for muscular dystrophies LEARN MORE

Home
About
R&D
CDMO
News
Contact
English
- Italian

Home
About
R&D
CDMO
News
Contact
English
- Italian

Alleanza Sabin-Reithera: da Barda 20 milioni

Alleanza Sabin-Reithera: da Barda 20 milioni

Alleanza Sabin-Reithera: da Barda 20 milioni

(Articolo tratto da Il Sole 24 Ore)

Alleanza Sabin-Reithera: da Barda 20 milioni2020-07-162020-11-12https://www.reithera.com/wp-content/uploads/2019/02/reithera_marchio_orz-1.pngReitherahttps://www.reithera.com/wp-content/uploads/2019/02/reithera_marchio_orz-1.png200px200px

Our privacy

Privacy Policy and Cookie Law

Modello Organizzativo 231

Follow us

linkedin
facebook
instagram
twitter

ReiThera srl is a biotech company developing products based on gene delivery technologies for advanced therapies, from early development to final QP release.

© Copyright 2018 | Made with by

Una password per sconfiggere il virusNews, Press Release

COVID-19 – AIFA autorizza la sperimentazione di fase I del vaccino ReiThera in ItaliaNews, Press Release